Gustavo Turecki, MD, PhD

• Scientific Director, Douglas Institute
• Chair, Department of Psychiatry, McGill University
• Chief of Psychiatry, CIUSSS Montreal West Island
• Director, McGill Group for Suicide Studies, Douglas Institute
• Co-Director, Douglas – Bell Canada Brain Bank (suicide studies), Douglas Research Centre
• Head, Depressive Disorders Program, Douglas Institute

Gustavo Turecki, MD, PhD is a clinician-scientist investigating the neurobiology of depression and suicide, with a particular interest on functional genomics and epigenetics. Dr. Turecki's work uses clinical and basic research approaches, and has significantly advanced knowledge on mechanisms leading to suicide and suicidal behaviour. At a molecular level, he investigates the role of epigenetic risk factors on risk for major depression and suicidal behaviour.

He is a Professor and the Chair of the Department of Psychiatry at McGill University and the Director of the McGill Group for Suicide Studies (MGSS), a world-leading multidisciplinary suicide research group with researchers in psychology, epidemiology, anatomy and molecular biology. Dr. Turecki is also the Scientific Director of the Douglas Research Centre. Finally, as a clinician, he is the Psychiatrist-in-Chief of the Douglas Mental Health University Institute and associated hospitals and heads the Depressive Disorders Program at the Douglas Mental Health University Institute, where he treats patients with refractory major depressive disorder.

• Visit Google Scholar for latest publications.